VXRT
Vaxart Inc
Price:  
0.32 
USD
Volume:  
24,017,526.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VXRT EV/EBITDA

10546.2%
Upside

As of 2026-06-13, the EV/EBITDA ratio of Vaxart Inc (VXRT) is 2.46. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VXRT's latest enterprise value is 112.35 mil USD. VXRT's TTM EBITDA according to its financial statements is 45.64 mil USD. Dividing these 2 quantities gives us the above VXRT EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 14.0x - 15.5x 14.8x
Forward P/E multiples 15.0x - 20.0x 17.5x
Fair Price 1.40 - 76.18 34.07
Upside 337.4% - 23705.3% 10546.2%
0.32 USD
Stock Price
34.07 USD
Fair Price

VXRT EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-06-01 5.77
2026-05-29 5.93
2026-05-28 6.11
2026-05-27 5.84
2026-05-26 5.80
2026-05-22 5.93
2026-05-21 6.30
2026-05-20 5.56
2026-05-19 5.56
2026-05-18 5.75
2026-05-15 6.31
2026-05-14 5.99
2026-05-13 6.41
2026-05-12 6.28
2026-05-11 6.01
2026-05-08 6.52
2026-05-07 6.95
2026-05-06 7.00
2026-05-05 7.11
2026-05-04 7.14
2026-05-01 7.27
2026-04-30 7.27
2026-04-29 7.12
2026-04-28 7.11
2026-04-27 7.36
2026-04-24 6.74
2026-04-23 6.95
2026-04-22 6.93
2026-04-21 7.13
2026-04-20 7.16
2026-04-17 7.06
2026-04-16 6.82
2026-04-15 6.84
2026-04-14 6.63
2026-04-13 6.51
2026-04-10 5.77
2026-04-09 5.73
2026-04-08 5.77
2026-04-07 5.67
2026-04-06 5.76
2026-04-02 5.56
2026-04-01 5.77
2026-03-31 5.51
2026-03-30 5.45
2026-03-27 5.99
2026-03-26 6.29
2026-03-25 6.29
2026-03-24 6.46
2026-03-23 6.74
2026-03-20 5.86